{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Overactive Bladder Management: Cognitive Risk With Anticholinergics and Alternative Management Options for the General Practitioner

Activity Steps

Description

NOTE: Individual subscribers will be required to submit payment before viewing. Users accessing via an institutional subscription can proceed without payment.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Explain the diagnostic criteria of overactive bladder (OAB).
  2. Describe various treatment options for OAB.
  3. Differentiate risks of medications prescribed for OAB and explain patient selection for use of trospium, mirabegron, or vibegron before urogynecology referral.

Learning Outcomes

Seventy-five percent of participants will demonstrate knowledge of the association between specific overactive bladder (OAB) anticholinergic medication and dementia as well as alternative oral medication treatment options for OAB by achieving a minimum score of 70% on the outcomes-based posttest.
Price: $49.00

Credits:

  • ANCC 2.0 CH / 2.0 APH
  • DC - BON 2.0 CH
  • FL - BON 2.0 CH
  • GA - BON 2.0 CH
  • NM - BON 2.0 CH
  • SC - BON 2.0 CH
  • WV - BOERN 2.0 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.

Advanced Pharmacology Hours













Test Code: PGO0323B
Published: March 31, 2023
Expires: 3/6/2026
Required Passing Score: 7/10 (70%)
Authors: Miriam R. Raffeld, MD; Avita Pahwa, MD; Carol Glowacki, MD